Axodin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-06-2024
- Paid Up Capital ₹ 1.00 M
as on 23-06-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.21 Cr
as on 23-06-2024
- Satisfied Charges ₹ 2.50 M
as on 23-06-2024
- Revenue 54.31%
(FY 2022)
- Profit 49.66%
(FY 2022)
- Ebitda 35.18%
(FY 2022)
- Net Worth 22.86%
(FY 2022)
- Total Assets 20.65%
(FY 2022)
About Axodin Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.21 Cr. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Darshana Devi and Rahul Saini serve as directors at the Company.
- CIN/LLPIN
U24230HR2016PTC064965
- Company No.
064965
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2016
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Ambala City, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Axodin Pharmaceuticals Private Limited offer?
Axodin Pharmaceuticals Private Limited offers a wide range of products and services, including Respiratory System Drugs, Anti Asthma Drug, Common Disease Medicines, Injectable Products, Multivitamin Syrup & Drops, Vitamin B Complex Syrup, Essential & Aromatic Oils, Seeds Oil and Fruit Oils, Nutraceuticals & Dietary Supplements, Nutritional Supplements.
Who are the key members and board of directors at Axodin Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darshana Devi  | Director | 25-Jul-2016 | Current |
| Rahul Saini | Director | 11-Jul-2016 | Current |
Financial Performance of Axodin Pharmaceuticals.
Axodin Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 54.31% increase. The company also saw a substantial improvement in profitability, with a 49.66% increase in profit. The company's net worth Soared by an impressive increase of 22.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Axodin Pharmaceuticals?
In 2022, Axodin Pharmaceuticals had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 Dec 2022 | ₹2.09 M | Open |
Hdfc Bank Limited Creation Date: 01 Jul 2020 | ₹1.00 Cr | Open |
Others Creation Date: 12 Oct 2016 | ₹2.50 M | Satisfied |
How Many Employees Work at Axodin Pharmaceuticals?
Unlock and access historical data on people associated with Axodin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Axodin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axodin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
